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Abstract
Independent monitor unit (MU) calculations are a vital part of radiotherapy treatment
planning quality assurance. In the case of complex treatment planning methods, such as
intensity modulated radiotherapy (IMRT), traditional independent monitor unit
calculations using tables of beam data and manual calculations are inadequate.
Recently, computer programs have been developed that can perform independent
monitor unit calculations for IMRT treatment plans using scatter summation methods.
One such program is RadCalc, produced by Lifeline Software Inc. The purpose of this
project was to test RadCalc, and determine whether it is suitable for routine use in
IMRT treatment planning quality assurance.
Once the software was installed, beam data measured on the treatment linear accelerator
(linac) was imported into RadCalc, to be used in MU calculations. RadCalc was tested
for data integrity to ensure that the correct data was accessed for its calculations. The
interface between RadCalc and the treatment planning system, Pinnacle3, was set up so
that treatment plan data could be imported directly from Pinnacle3 into RadCalc. Test
plans were imported into RadCalc to ensure the Pinnacle3-RadCalc interface was
working correctly.
Test plans were created with open, blocked, segmented and IMRT fields, and delivered
to a phantom on the linac to test RadCalc’s block correction algorithm. Doses were
measured using a thimble ionisation chamber, and compared to the doses calculated by
RadCalc and Pinnacle3. The agreement between RadCalc and measured doses for most
situations was comparable to the agreement between Pinnacle3 and measured doses.
However, a systematic difference between RadCalc and measured dose was shown to
occur for asymmetric fields. In addition to this, an increase in the level of blocking of
the calculation point for segmented and IMRT fields appeared to increase the difference
between RadCalc and measured dose.
Thirty-two patient IMRT plans at the Illawarra Cancer Care Centre (ICCC) were
verified by reproducing the plan using a phantom CT dataset, and then delivering the
fields to the phantom and measuring the delivered dose. This data was compared to the
doses calculated by RadCalc and Pinnacle3. The doses calculated by RadCalc and
xix

Pinnacle3 for the plans created on patient CT datasets were also compared. In analysing
the data, a systematic difference between RadCalc and measured dose was detected.
Improved agreement was achieved by adjusting the MLC transmission parameter in
RadCalc. The average percentage difference per field for the phantom plans between
RadCalc and measured dose was 0.1% with a standard deviation 5.3%, while the
average percentage difference between Pinnacle3 and measured dose was -0.2% with a
standard deviation of 4.2%. The average percentage difference for total plan dose for
the phantom plans between RadCalc and measured dose was 0.0% with a standard
deviation 1.7%, while the average percentage difference between Pinnacle3 and
measured dose was -0.3% with a standard deviation of 1.1%. For the patient plans, the
average percentage difference per field between RadCalc and Pinnacle3 was 0.8% with
a standard deviation of 5.6%, while the average percentage difference per plan was
1.1% with a standard deviation of 1.1%.
The final recommendation is that RadCalc is accurate enough for routine IMRT
treatment planning quality assurance. A physical measurement should accompany the
RadCalc check to verify the transfer of data to the record and verify system and the dose
delivery process.
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